| Clinical features of vaccine-induced immune thrombocytopenia and thrombosis S Pavord, M Scully, BJ Hunt, W Lester, C Bagot, B Craven, A Rampotas, ... New England Journal of Medicine 385 (18), 1680-1689, 2021 | 544 | 2021 |
| Real-world evidence of caplacizumab use in the management of acute TTP T Dutt, RJ Shaw, MJ Stubbs, J Yong, B Bailiff, T Cranfield, MP Crowley, ... Blood, 2020 | 132* | 2020 |
| Platelet aggregates, a marker of severe COVID-19 disease A Rampotas, S Pavord Journal of clinical pathology 74 (11), 750-751, 2021 | 54 | 2021 |
| Platelet transfusion: Alloimmunization and refractoriness CF Prodger, A Rampotas, LJ Estcourt, SJ Stanworth, MF Murphy Seminars in Hematology 57 (2), 92-99, 2020 | 30 | 2020 |
| A real‐world study of immune thrombocytopenia management during the COVID‐19 pandemic in the UK A Rampotas, E Watson, K Burton, QA Hill, S Pavord British Journal of Haematology 196 (2), 351-355, 2022 | 17 | 2022 |
| Evaluating the educational environment of an international animal model-based wet lab course for undergraduate students MC Sideris, AE Papalois, T Athanasiou, I Dimitropoulos, K Theodoraki, ... Annals of Medicine and Surgery 12, 8-17, 2016 | 14 | 2016 |
| Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: a UK and Ireland analysis A Rampotas, MR Wilson, O Lomas, N Denny, H Leary, G Ferguson, ... British Journal of Haematology 194 (2), 365-377, 2021 | 13 | 2021 |
| Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK—a multicentre observational study DJ Arachchillage, I Rajakaruna, Z Odho, C Crossette‐Thambiah, ... British journal of haematology 196 (1), 79-94, 2022 | 11 | 2022 |
| Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019 TP Bull, R McCulloch, PLR Nicolson, AJ Doyle, RJ Shaw, A Langridge, ... Journal of Thrombosis and Haemostasis 20 (6), 1428-1436, 2022 | 10 | 2022 |
| A single centre retrospective study of low dose prophylaxis with extended half‐life factor IX for severe haemophilia B A Rampotas, MJR Desborough, S Raza‐Burton, S Taylor, A Wilkinson, ... Haemophilia 26 (2), 278-281, 2020 | 10 | 2020 |
| Autoimmune disease and COVID-19: a multicentre observational study in the United Kingdom DJ Arachchillage, I Rajakaruna, C Pericleous, PLR Nicolson, M Makris, ... Rheumatology 61 (12), 4643-4655, 2022 | 8 | 2022 |
| Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma A Rampotas, G Sangha, GP Collins Therapeutic Advances in Hematology 12, 20406207211053120, 2021 | 8 | 2021 |
| The use of theatre in medical education in the emergency cases school: an appealing and widely accessible way of learning C Keskinis, V Bafitis, P Karailidou, C Pagonidou, P Pantelidis, ... Perspectives on medical education 6, 199-204, 2017 | 7 | 2017 |
| A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia: results of the first HaemSTAR “Flash-Mob” retrospective study … HaemSTAR Collaborators British Journal of Haematology 196 (2), 433-437, 2021 | 6 | 2021 |
| Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study F Djebbari, A Rampotas, G Vallance, F Panitsas, N Basker, G Sangha, ... Hematology 27 (1), 691-699, 2022 | 5 | 2022 |
| Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort … F Djebbari, A Rampotas, F Panitsas, WY Lim, C Lees, I Tsagkaraki, ... Plos one 17 (1), e0262388, 2022 | 5 | 2022 |
| Variability of different reference bodies in normal, keratoconus, and collagen crosslinked corneas G Labiris, A Giarmoukakis, A Rampotas, M Symeou, P Bougatsou, ... European Journal of Ophthalmology 25 (6), 468-473, 2015 | 5 | 2015 |
| Treatment discontinuation patterns for patients with chronic lymphocytic leukemia in real-world settings: results from a multi-center international study M Shadman, BS Manzoor, K Sail, HH Tuncer, JN Allan, C Ujjani, ... Clinical Lymphoma Myeloma and Leukemia 23 (7), 515-526, 2023 | 4 | 2023 |
| Venetoclax ramp‐up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study R Figueroa‐Mora, A Rampotas, D Halperin, T Worth, J Vidler, D Melotti, ... British Journal of Haematology 202 (1), 48-53, 2023 | 4 | 2023 |
| Myeloma care adaptations in the UK during SARS‐CoV‐2 pandemic: Challenges and measurable outcomes F Djebbari, F Panitsas, FA Sharpley, A Rampotas, J Larham, S Moore, ... European Journal of Haematology 105 (5), 662, 2020 | 4 | 2020 |
